Your browser doesn't support javascript.
loading
The 'top 100' drugs and classes in England: an updated 'starter formulary' for trainee prescribers.
Audi, Selma; Burrage, Daniel R; Lonsdale, Dagan O; Pontefract, Sarah; Coleman, Jamie J; Hitchings, Andrew W; Baker, Emma H.
Afiliação
  • Audi S; Clinical Pharmacology, Institute of Infection and Immunity, St George's, University of London.
  • Burrage DR; Clinical Pharmacology, Institute of Infection and Immunity, St George's, University of London.
  • Lonsdale DO; St George's University Hospitals NHS Foundation Trust.
  • Pontefract S; Clinical Pharmacology, Institute of Infection and Immunity, St George's, University of London.
  • Coleman JJ; St George's University Hospitals NHS Foundation Trust.
  • Hitchings AW; Institute of Clinical Sciences, University of Birmingham.
  • Baker EH; University Hospital Birmingham NHS Foundation Trust.
Br J Clin Pharmacol ; 84(11): 2562-2571, 2018 11.
Article em En | MEDLINE | ID: mdl-29975799
ABSTRACT

AIMS:

Prescribing is a complex skill required of doctors and, increasingly, other healthcare professionals. Use of a personal formulary can help to develop this skill. In 2006-9, we developed a core list of the 100 most commonly prescribed drugs. Our aim in the present study was to update this 'starter formulary' to ensure its continued relevance for prescriber training.

METHODS:

We analysed large contemporary primary and secondary care datasets to identify the most frequently prescribed medicinal products. Items were classified into natural groups, broadly following their British National Formulary classification. The resulting drug groups were included in the core list if they comprised ≥0.1% prescriptions in both settings or ≥0.2-0.3% prescriptions in one setting. Drugs from emergency guidelines that did not qualify by prescribing frequency completed the list.

RESULTS:

Over 1 billion primary care items and approximately 1.8 million secondary care prescriptions were analysed. The updated list comprises 81 drug groups commonly prescribed in both settings; six from primary care; seven from secondary care; and six from emergency guidelines. Eighty-eight per cent of the formulary was unchanged. Notable changes include entry of newer anti-epileptics and dipeptidyl peptidase-4 inhibitors and exit of phenytoin and thiazolidinediones.

CONCLUSIONS:

The relative stability of the core drug list over 9 years and the current update ensure that learning based on this list remains relevant to practice. Trainee prescribers may be encouraged to use this 'starter formulary' to develop a sound basis of prescribing knowledge and skills that they can subsequently apply more widely.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Prescrições de Medicamentos / Padrões de Prática Médica / Medicamentos sob Prescrição / Formulários Farmacêuticos como Assunto Tipo de estudo: Guideline / Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Prescrições de Medicamentos / Padrões de Prática Médica / Medicamentos sob Prescrição / Formulários Farmacêuticos como Assunto Tipo de estudo: Guideline / Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2018 Tipo de documento: Article